Bovine herpesvirus 1 (ATCC® VR-2181)

Classification: Herpesviridae, Varicellovirus  /  Product Format: frozen

Classification Herpesviridae, Varicellovirus
Deposited As Infectious bovine rhinotracheitis virus
Agent Bovine herpesvirus 1
Strain IBRV(NG)dltkdlgIII
Common Name Infectious bovine rhinotracheitis virus, Bovine rhinotracheitis virus
Applications
An attenuated virus produced by recombinant technology that is TK and gIII negative.
An attenuated virus produced by recombinant technology that is TK and gIII negative.
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions -70°C or colder
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Comments
An attenuated virus produced by recombinant technology that is TK and gIII negative.
Use BHV-negative FBS or lamb sera to supplement growth medium.
Effect on Host
Cytopathic effects (typical herpesvirus CPE)
Recommended Host
RAB-9 cells (ATCC CRL-1414)
RAB-9 cells (ATCC CRL-1414); bovine embryo cells; bovine kidney cells; bovine turbinate cells
Growth Conditions
Incubation: 3-4 days at 34.5°C
Effect on Host
Cytopathic effects (typical herpesvirus CPE)
Name of Depositor S Kit
U.S. Patent
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
References

Kit M, et al. Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same. US Patent 4,992,051 dated Feb 12 1991

Kit M, et al. Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same. US Patent 5,128,129 dated Jul 7 1992